Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health Hero Network

This article was originally published in The Gray Sheet

Executive Summary

Internet-based health care management concern receives FDA clearance for blood glucose meter connectivity with its Health Buddy appliance to collect biometric data obtained from blood glucose meters and to transmit it via the Internet to the patient's physician, the firm announces Dec. 2. Part of the firm's Health Hero communications platform, which is used at home by patients to receive and respond to reminders and questions from their providers, the Health Buddy is the first biometric data collection and transmission system cleared by FDA

You may also be interested in...

CMS Telehealth Demo Supports Health Buddy As Aid To Chronic Care Coordination

After analyzing a 2006-2007 CMS demonstration project on the integration of telehealth technology with chronic care management services, a Stanford University researcher says the cost savings were significant enough to merit a closer look.

Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies

Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts